Table 2 The correlation between PSMD1 expression and clinicopathological parameters (n = 84).
Variables | TMEM165 Expression | p | |
---|---|---|---|
 < 1.5 fold | ≧1.5 fold | ||
Gender | |||
Male | 38 | 36 | 0.369 |
Female | 4 | 6 | |
Age (year) | |||
 < 52 | 16 | 20 | 0.254 |
 ≥ 52 | 26 | 22 | |
AFP (ng/mL) | |||
 < 100 | 32 | 18 | 0.001 |
 ≥ 100 | 9 | 24 | |
AST (U/L) | |||
 < 40 | 20 | 18 | 0.413 |
 ≥ 40 | 22 | 24 | |
ALT (U/L) | |||
 < 35 | 12 | 19 | 0.117 |
 ≥ 35 | 29 | 24 | |
Child–Pugh classification | |||
A | 34 | 34 | 0.515 |
B | 3 | 4 | |
Tumor size (cm) | |||
 < 7 | 32 | 23 | 0.044 |
 ≥ 7 | 10 | 18 | |
Tumor stage | |||
I, II | 18 | 14 | 0.113 |
III, IV | 10 | 17 | |
Tumor number | |||
Single | 29 | 28 | 0.5 |
Multiple | 8 | 9 | |
Macroscopic vascular invasion | |||
No | 38 | 36 | 0.488 |
Yes | 2 | 3 | |
Microscopic vascular invasion | |||
No | 17 | 17 | 0.549 |
Yes | 19 | 18 | |
Edmondoson grade | |||
I, II | 27 | 28 | 0.438 |
III, IV | 15 | 13 | |
Cirrhosis | |||
No | 24 | 22 | 0.355 |
Yes | 14 | 17 |